Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

F147 - Atopic Dermatitis in Adults: Not Just Big Kids

Monday, February 19; 3:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Describe the various presentations and differential diagnosis of atopic dermatitis in adults
  • Identify key differences between atopic dermatitis in children and adults
  • Discuss treatment considerations for atopic dermatitis in adults

Description

The intended audience is general adult dermatologists. Atopic dermatitis is one of the most common chronic inflammatory skin disorders encountered by dermatologists. Virtually every dermatologist has multiple patients with adult atopic dermatitis. Adults with atopic dermatitis have a number of key differences in their risk factors, triggers, presentation and clinical course than children. These often pose major clinical challenges and are often very frustrating to dermatologists. Dermatologists must be able to recognize these differences, in order to make the best treatment decisions and achieve optimal outcomes.

Disclosures

  • Silverberg, Jonathan I., MD, PhD, MPH: AbbVie – C(H), I(NC); AnaptysBio – C(H); Asana Biosciences, LLC – C(H); Eli Lilly and Company – C(H), I(NC); Galderma Research & Development, LLC – C(H); GlaxoSmithKline – C(H), I(NC); Glenmark Generics Inc. – C(H); Kiniksa Pharmaceuticals, Ltd. – C(H), I(NC); Leo Pharma Inc – A(H); Leo Pharma Inc. – I(H); Medimmune – C(H); Menlo Therapeutics – A(H), I(NC); Pfizer Inc. – A(H), C(H); PuriCore, Inc. – C(H); Regeneron – C(H), I(NC), SP(H); Sanofi – C(Grants/Research Funding);
Event Details
  • Date
    Monday, February 19
  • Time
    3:30 PM - 5:30 PM
  • Location
    Room 32B
  • CME Credits
    2.00
  • Type
    New
Directors/Co-Directors
  • Jonathan I. Silverberg, MD, PhD, MPH, FAAD